Incanthera
Bradford, GB · 1 known investors
Find your way into Incanthera
Sign up to see every warm intro you have to Incanthera
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Incanthera team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Incanthera develops and commercializes therapeutics derived from the Institute of Cancer Therapeutics in Bradford. The company operates a direct-to-consumer model with a global network of influencers and ambassadors, targeting multi-billion dollar markets outside the US.
Investors · 1
Companies House · registry record
View on Companies House ↗- Registered name
- INCANTHERA PLC
- Company number
- 11026926
- Status
- Active
- Company type
- Public limited company
- Incorporated
- 23 Oct 2017
- Registered office
- C/O Gateley Legal, Ship Canal House, 98 King Street, Manchester, Greater Manchester, M2 4WU
- Nature of business (SIC)
- 72190 — Other research and experimental development on natural sciences and engineering
- Previous names
- PROJECT BRADFORD PLC (2017–2020)
- Accounts
- last made up to 31 Mar 2025 · next due 30 Sept 2026
- Confirmation statement
- last made up to 22 Oct 2025 · next due 5 Nov 2026
Current officers · 6
- Laura Jane Brogden — director, appointed 13 Jul 2026
- Werner Buerki — director, appointed 13 Jul 2026
- John Michael George Howes — director, appointed 10 Jun 2024
- Caroline Diana Murray — director, appointed 23 Feb 2022
- Stuart Kinnear Robertson — director, appointed 3 Jun 2026
- Simon Julian Ward — director, appointed 23 Oct 2017
Source: Companies House public register · retrieved 6 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Incanthera do?
- Incanthera develops and commercializes therapeutics derived from the Institute of Cancer Therapeutics in Bradford. The company operates a direct-to-consumer model with a global network of influencers and ambassadors, targeting multi-billion dollar markets outside the US.
- Who are Incanthera's investors?
- Incanthera's investors include IW Capital.
- Where is Incanthera headquartered?
- Incanthera is headquartered in Bradford, GB.
